The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability
Open accessAbstract
Many approaches have been developed over time to overcome the bioavailability limitations of poorly soluble drugs. With the advances in nanotechnology in recent decades, science and industry have been approaching this issue through the formulation of drugs as nanocrystals, which consist of “pure drugs and a minimum of surface active agents required for stabilization”. They are defined as “carrier-free submicron colloidal drug delivery systems with a mean particle size in the nanometer range, typically between 10–800 nm”. The primary importance of these nanoparticles was the reduction of particle size to nanoscale dimensions, with an increase in the particle surface area in contact with the dissolution medium, and thus in bioavailability. This approach has been proven successful, as demonstrated by the number of such drug products on the market. Nonetheless, despite the definition that indicates nanocrystals as a “carrier-free” system, surface active agents are necessary to prevent colloidal particles aggregation and thus improve stability. In addition, in more recent years, nanocrystal properties and technologies have attracted the interest of researchers as a means to obtain colloidal particles with modified biological properties, and thus their interest is now also addressed to modify the drug delivery and targeting. The present work provides an overview of the achievements in improving the bioavailability of poorly soluble drugs according to their administration route, describes the methods developed to overcome physicochemical and stability-related problems, and in particular reviews different stabilizers and surface agents that are able to modify the drug delivery and targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Synthesis and Characterization of Monodisperse Nanocrystals and Close-Packed Nanocrystal Assemblies
Murray, C. B., Kagan, C. R., & Bawendi, M. G. (2000) · Annual Review of Materials Science · doi:10.1146/annurev.matsci.30.1.545 · Cited by 4,353
International Journal of Nanomedicine
(2020) · International Journal of Nanomedicine · doi:10.2147/ijn · Cited by 2,747
International Journal of Pharmaceutics
He, W., Yang, K., Fan, L., Lv, Y., Zhu, J., Zhu, S., Qin, C., Wang, Y., & Yin, L. (2015) · Cited by 2,639
Characteristics and Significance of the Amorphous State in Pharmaceutical Systems
Hancock, B. C., & Zografi, G. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js9601896 · Cited by 1,922
THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.
Noyes, A. A., & Whitney, W. R. (1897) · Journal of the American Chemical Society · doi:10.1021/ja02086a003 · Cited by 1,884
Derjaguin, B., & Landau, L. (1993) · Progress in Surface Science · doi:10.1016/0079-6816(93)90013-l · Cited by 1,802
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates
Blagden, N., de Matas, M., Gavan, P. T., & York, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.011 · Cited by 1,448
Amorphous pharmaceutical solids: preparation, characterization and stabilization
Yu, L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00098-9 · Cited by 1,405
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
What is the True Solubility Advantage for Amorphous Pharmaceuticals?
Hancock, B. C., & Parks, M. (2000) · Pharmaceutical Research · doi:10.1023/a:1007516718048 · Cited by 1,358
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation
KECK, C., & MULLER, R. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.05.009 · Cited by 1,061
Pharmaceutical applications of cyclodextrins: basic science and product development
Loftsson, T., & Brewster, M. E. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01030.x · Cited by 1,031
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
Ventola, C. L. (2017) · Europe PMC (PubMed Central) · Cited by 835
Muller, R. H., & Keck, C. M. (2004) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2004.06.007 · Cited by 819
Shegokar, R., & Müller, R. H. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.044 · Cited by 740
Liversidge, G. G., & Cundy, K. C. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)00122-y · Cited by 739
Van Eerdenbrugh, B., Van den Mooter, G., & Augustijns, P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.023 · Cited by 717
Müller, R. H., Gohla, S., & Keck, C. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.01.007 · Cited by 702
A General Approach to Binary and Ternary Hybrid Nanocrystals
Shi, W., Zeng, H., Sahoo, Y., Ohulchanskyy, T. Y., Ding, Y., Wang, Z. L., Swihart, M., & Prasad, P. N. (2006) · Nano Letters · doi:10.1021/nl0600833 · Cited by 608
Merisko-Liversidge, E., & Liversidge, G. G. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.12.007 · Cited by 608
Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 579
Oral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Hybrid Nanoparticles for Detection and Treatment of Cancer
Sailor, M. J., & Park, J. (2012) · Advanced Materials · doi:10.1002/adma.201200653 · Cited by 487
Zhang, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.009 · Cited by 462
Production methods for nanodrug particles using the bottom-up approach
Chan, H.-K., & Kwok, P. C. L. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.011 · Cited by 451
Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs
Junyaprasert, V. B., & Morakul, B. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.005 · Cited by 443
Drug nanocrystals in the commercial pharmaceutical development process
Möschwitzer, J. P. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.09.034 · Cited by 432
Jermain, S. V., Brough, C., & Williams, R. O. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.051 · Cited by 431
Huang, X., Peng, X., Wang, Y., Wang, Y., Shin, D. M., El-Sayed, M. A., & Nie, S. (2010) · ACS Nano · doi:10.1021/nn102055s · Cited by 427
Gao, L., Zhang, D., & Chen, M. (2008) · Journal of Nanoparticle Research · doi:10.1007/s11051-008-9357-4 · Cited by 420
Peltonen, L., & Hirvonen, J. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01022.x · Cited by 405
Pharmaceutical nanocrystals: production by wet milling and applications
Malamatari, M., Taylor, K. M. G., Malamataris, S., Douroumis, D., & Kachrimanis, K. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.016 · Cited by 369
Drug nanocrystals: in vivo performances.
Gao, L., Liu, G., Ma, J., Wang, X., Zhou, L., & Li, X. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.013 · Cited by 347
Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.014 · Cited by 339
Solid State Amorphization of Pharmaceuticals
Willart, J. F., & Descamps, M. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800092t · Cited by 332
Production and characterization of Hesperetin nanosuspensions for dermal delivery
Mishra, P. R., Shaal, L. A., Müller, R. H., & Keck, C. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.12.030 · Cited by 308
Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery
Brough, C., & Williams, R. O. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.061 · Cited by 288
Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs
KASSEM, M., ABDELRAHMAN, A., GHORAB, M., AHMED, M., & KHALIL, R. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.011 · Cited by 279
Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery
Pawar, V. K., Singh, Y., Meher, J. G., Gupta, S., & Chourasia, M. K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.030 · Cited by 250
Targeting of albumin-embedded paclitaxel nanoparticles to tumors
Karmali, P. P., Kotamraju, V. R., Kastantin, M., Black, M., Missirlis, D., Tirrell, M., & Ruoslahti, E. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.07.007 · Cited by 234
Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J. M., Pugh, S., Polin, L., et al. (1996) · Pharmaceutical Research · doi:10.1023/a:1016051316815 · Cited by 230
Nanomedicines for ocular NSAIDs: safety on drug delivery
Araújo, J., Gonzalez, E., Egea, M. A., Garcia, M. L., & Souto, E. B. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.02.003 · Cited by 223
Bhakay, A., Rahman, M., Dave, R. N., & Bilgili, E. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030086 · Cited by 215
Onoue, S., Takahashi, H., Kawabata, Y., Seto, Y., Hatanaka, J., Timmermann, B., & Yamada, S. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21964 · Cited by 206
Hollis, C. P., Weiss, H. L., Leggas, M., Evers, B. M., Gemeinhart, R. A., & Li, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.039 · Cited by 204
Pardeike, J., Strohmeier, D. M., Schrödl, N., Voura, C., Gruber, M., Khinast, J. G., & Zimmer, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.033 · Cited by 204
Evaluation of nano- and microparticle uptake by the gastrointestinal tract
Delie, F. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00041-6 · Cited by 202
Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract
Ponchel, G., Montisci, M.-J., Dembri, A., Durrer, C., & Duchêne, D. (1997) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00098-2 · Cited by 191
Injected nanocrystals for targeted drug delivery
Lu, Y., Li, Y., & Wu, W. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2015.11.005 · Cited by 191
Production of pure drug nanocrystals and nano co-crystals by confinement methods
Fontana, F., Figueiredo, P., Zhang, P., Hirvonen, J. T., Liu, D., & Santos, H. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.05.002 · Cited by 183
Drug nanocrystals – Versatile option for formulation of poorly soluble materials
Peltonen, L., & Hirvonen, J. J. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.12.005 · Cited by 182
Zhao, H., Wang, J.-X., Wang, Q.-A., Chen, J.-F., & Yun, J. (2007) · Industrial & Engineering Chemistry Research · doi:10.1021/ie070498e · Cited by 169
Paclitaxel Nanocrystals for Overcoming Multidrug Resistance in Cancer
Liu, Y., Huang, L., & Liu, F. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100012s · Cited by 168
Lutein nanocrystals as antioxidant formulation for oral and dermal delivery
Mitri, K., Shegokar, R., Gohla, S., Anselmi, C., & Müller, R. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.026 · Cited by 163
Production of protein nanoparticles by electrospray drying
Gomez, A., Bingham, D., Juan, L. D., & Tang, K. (1998) · Journal of Aerosol Science · doi:10.1016/s0021-8502(97)10031-3 · Cited by 161
Sievens-Figueroa, L., Bhakay, A., Jerez-Rozo, J. I., Pandya, N., Romañach, R. J., Michniak-Kohn, B., Iqbal, Z., Bilgili, E., & Davé, R. N. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.12.001 · Cited by 161
Development of Curcumin Nanocrystal: Physical Aspects
Rachmawati, H., Shaal, L. A., Müller, R. H., & Keck, C. M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23335 · Cited by 160
Targeted Cancer Therapy With Novel High Drug-Loading Nanocrystals
Liu, F., Park, J.-Y., Zhang, Y., Conwell, C., Liu, Y., Bathula, S. R., & Huang, L. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22112 · Cited by 159
Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions
Gao, L., Zhang, D., Chen, M., Duan, C., Dai, W., Jia, L., & Zhao, W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.016 · Cited by 158
Ige, P. P., Baria, R. K., & Gattani, S. G. (2013) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2013.02.043 · Cited by 156
Fabrication of quercetin nanocrystals: Comparison of different methods
Kakran, M., Shegokar, R., Sahoo, N. G., Shaal, L. A., Li, L., & Müller, R. H. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.08.006 · Cited by 147
Shaal, L. A., Shegokar, R., & Müller, R. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.08.018 · Cited by 142
Yang, W. P., Johnston, K. P., & Williams, R. O. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.01.011 · Cited by 140
Yang, C., Gao, S., Dagnæs‐Hansen, F., Jakobsen, M., & Kjems, J. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b16556 · Cited by 139
Effect of wet milling process on the solid state of indomethacin and simvastatin
Sharma, P., Denny, W. A., & Garg, S. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.029 · Cited by 134
Long distance forces acting between colloidal particles
Verwey, E. J. W., & Overbeek, J. T. G. (1946) · Transactions of the Faraday Society · doi:10.1039/tf946420b117 · Cited by 129
Combinative Particle Size Reduction Technologies for the Production of Drug Nanocrystals
Salazar, J., Müller, R. H., & Möschwitzer, J. P. (2014) · Journal of Pharmaceutics · doi:10.1155/2014/265754 · Cited by 123
Ganta, S., Paxton, J. W., Baguley, B. C., & Garg, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.022 · Cited by 122
Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation
Lü, Y., Wang, Z., Li, T., McNally, H. A., Park, K., & Sturek, M. S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.018 · Cited by 121
Vidlářová, L., Romero, G. B., Hanuš, J., Štĕpánek, F., & Müller, R. H. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.004 · Cited by 120
Preparation and characterization of intravenously injectable nimodipine nanosuspension
Xiong, R., Lu, W., Li, J., Wang, P., Xu, R., & Chen, T. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.036 · Cited by 108
Shegokar, R., & Singh, K. K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.09.041 · Cited by 105
Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets
Lai, F., Pini, E., Angioni, G., Manca, M. L., Perricci, J., Sinico, C., & Fadda, A. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.07.005 · Cited by 105
Development Considerations for Nanocrystal Drug Products
Chen, M., John, M. D., Lee, S. L., & Tyner, K. M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0064-x · Cited by 103
A Brief Literature and Patent Review of Nanosuspensions to a Final Drug Product
Chin, W. W. L., Parmentier, J., Widzinski, M., Tan, E. H., & Gokhale, R. D. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24098 · Cited by 100
Havel, H. A. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9970-6 · Cited by 99
Langguth, P., Hanafy, A., Frenzel, D., Grenier, P., Nhamias, A., Ohlig, T., Vergnault, G., & Spahn-Langguth, H. (2005) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-52182 · Cited by 98
Development of cationic nanocrystals for ocular delivery
Romero, G. B., Keck, C. M., Müller, R. H., & Bou‐Chacra, N. A. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.07.005 · Cited by 95
Nanoparticles: A personal experience for formulating poorly water soluble drugs
Cooper, E. R. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.006 · Cited by 92
Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis
Zhang, H., Hu, H., Zhang, H., Dai, W., Wang, X., Wang, X., & Zhang, Q. (2015) · Nanoscale · doi:10.1039/c4nr07450e · Cited by 91
Fu, Q., Sun, J., Ai, X., Zhang, P., Li, M., Wang, Y., Liu, X., Sun, Y. H., Sui, X., Sun, L., et al. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.065 · Cited by 91
Niwa, T., Miura, S., & Danjo, K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.013 · Cited by 90
The BCS: Where Do We Go from Here?
Dressman, J., Butler, J., Hempenstall, J., & Reppas, C. I. (2001) · Pharmaceutical technology · Cited by 89
Wang, H., Zhu, W., Huang, Y., Li, Z., Jiang, Y., & Xie, Q. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.04.017 · Cited by 89
Zhai, X., Lademann, J. M., Keck, C. M., & Müller, R. H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.04.060 · Cited by 80
Chen, L., Wang, Y., Zhang, J., Hao, L., Guo, H., Lou, H., & Zhang, D. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.12.005 · Cited by 78
Effective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensions
Kim, S., & Lee, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.010 · Cited by 78
Arzi, R. S., & Sosnik, A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.012 · Cited by 78
Pireddu, R., Caddeo, C., Valenti, D., Marongiu, F., Scano, A., Ennas, G., Lai, F., Fadda, A. M., & Sinico, C. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.03.026 · Cited by 77
Kobierski, S., Ofori-Kwakye, K., Müller, R. H., & Keck, C. M. (2009) · Die Pharmazie · doi:10.31083/ph.2009.9097 · Cited by 76
Colombo, M., Staufenbiel, S., Rühl, E., & Bodmeier, R. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.02.030 · Cited by 76
Kayaert, P., & den Mooter, G. V. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.020 · Cited by 73
Döge, N., Hönzke, S., Schumacher, F., Balzus, B., Colombo, M., Hadam, S., Rancan, F., Blume‐Peytavi, U., Schäfer‐Korting, M., Schindler, A., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.009 · Cited by 72
Shubar, H. M., Lachenmaier, S., Heimesaat, M. M., Lohman, U., Mauludın, R., Mueller, R. H., Fitzner, R., Borner, K., & Liesenfeld, O. (2010) · Journal of drug targeting · doi:10.3109/10611861003733995 · Cited by 69
Effect of Polymer Molecular Weight on Nanocomminution of Poorly Soluble Drug
Choi, J.-Y., Park, C. H., & Lee, J. (2008) · Drug Delivery · doi:10.1080/10717540802039113 · Cited by 68
Novel nanosized formulations of two diclofenac acid polymorphs to improve topical bioavailability
Pireddu, R., Sinico, C., Ennas, G., Marongiu, F., Muzzalupo, R., Lai, F., & Fadda, A. M. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.06.006 · Cited by 65
PEG Nanocages as Non-sheddable Stabilizers for Drug Nanocrystals
Fuhrmann, K., Schulz, J. D., Gauthier, M. A., & Leroux, J. (2012) · ACS Nano · doi:10.1021/nn2046554 · Cited by 65
Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery
Chen, C., Wang, L., Cao, F., Miao, X., Chen, T., Chang, Q., & Zheng, Y. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.014 · Cited by 65
Magnetoresponsive Squalenoyl Gemcitabine Composite Nanoparticles for Cancer Active Targeting
Arias, J. L., Reddy, L. H., & Couvreur, P. (2008) · Langmuir · doi:10.1021/la800547s · Cited by 62
Advance of the application of nano-controlled release system in ophthalmic drug delivery
Wang, X., Wang, S., & Zhang, Y. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1116025 · Cited by 62
Chiou, H., Chan, H., Heng, D., Prud’homme, R. K., & Raper, J. A. (2008) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2008.02.002 · Cited by 61
Khinast, J., Baumgartner, R., & Roblegg, E. (2013) · AAPS PharmSciTech · doi:10.1208/s12249-013-9946-0 · Cited by 61
Yi, T., Tang, D., Wang, F., et al. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1259372 · Cited by 59
Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach
Iurian, S., Bogdan, C., Tomuță, I., Szabó‐Révész, P., Chvatal, A., Leucuta, S. E., Moldovan, M., & Ambrus, R. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.04.011 · Cited by 57
Lemke, A., Kiderlen, A. F., Petri, B., & Kayser, O. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.12.004 · Cited by 55
Sharma, S., Singh, J., Verma, A., Teja, B. V., Shukla, R. P., Singh, S. K., Sharma, V., Konwar, R., & Mishra, P. R. (2016) · RSC Advances · doi:10.1039/c6ra11260a · Cited by 52
Zhai, X., Lademann, J. M., Keck, C. M., & Müller, R. H. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.07.002 · Cited by 50
Gao, W., Chen, Y., Thompson, D. H., Park, K., & Li, T. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.015 · Cited by 49
Wang, T., Qi, J., Ding, N., Dong, X., Zhao, W., Lü, Y., Wang, C., & Wu, W. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.05.020 · Cited by 49
Nitrendipine Nanocrystals: Its Preparation, Characterization, and In Vitro–In Vivo Evaluation
Quan, P., Xia, D., Piao, H., Piao, H., Shi, K., Jia, Y., & Cui, F. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9682-2 · Cited by 47
Krull, S. M., Patel, H. V., Li, M., Bilgili, E. A., & Davé, R. N. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.07.005 · Cited by 47
Li, M., Ioannidis, N., Gogos, C. G., & Bilgili, E. A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.06.003 · Cited by 47
Poly(lactide-co-glycolide) nanoparticles for peroral delivery of bioactives
Grama, C. N., Ankola, D. D., & Kumar, M. N. V. R. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.11.005 · Cited by 45
Albendazole nanocrystals: Optimization, spectroscopic, thermal and anthelmintic studies
Koradia, K. D., Parikh, R. H., & Koradia, H. D. (2017) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2017.11.003 · Cited by 44
Liu, Y., Ma, Y., Xu, J., Chen, Y., Xie, J., Yue, P., Zheng, Q., & Ming, Y. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.10.009 · Cited by 38
Pandey, G., Mittapelly, N., Banala, V. T., & Mishra, P. R. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b18699 · Cited by 33
Nanotechnology approaches to pulmonary drug delivery
Gaul, R., Ramsey, J. M., Heise, A., Cryan, S., & Greene, C. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813667-6.00006-1 · Cited by 28
Aguiar, G. P. S., Marcon, M., Mocelin, R., Herrmann, A. P., Chaves, L. M. P. C., Piato, Â., Lanza, M., & de Oliveira, J. V. (2017) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2017.06.010 · Cited by 25
Folate-targeted drug-delivery systems prepared by nano-comminution
Kim, S., & Lee, J. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2010.496788 · Cited by 24
Zhan, H., & Liang, J. F. (2016) · Scientific Reports · doi:10.1038/srep38668 · Cited by 24
Mu, S., Li, M., Guo, M., Yang, W., Wang, Y., Li, J., Fu, Q., & He, Z. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.07.051 · Cited by 20
Tan, E. H., Parmentier, J., Low, A., & Möschwitzer, J. P. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.08.107 · Cited by 14
Hecq, J., Nollevaux, G., Deleers, M., Fanara, D., Vranckx, H., Peulen, O., Dandrifosse, G., & Amighi, K. (2006) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(06)50084-x · Cited by 12
Cited by
Emerging role of nanosuspensions in drug delivery systems
Jacob, S., Nair, A. B., & Shah, J. (2020) · Biomaterials Research · doi:10.1186/s40824-020-0184-8 · Cited by 415
Nanotechnology in Cosmetics and Cosmeceuticals—A Review of Latest Advancements
Gupta, V., Mohapatra, S., Mishra, H., Farooq, U., Kumar, K., Ansari, M., Aldawsari, M., Alalaiwe, A., Mirza, M., & Iqbal, Z. (2022) · Gels · doi:10.3390/gels8030173 · Cited by 370
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Jakubowska, E., & Lulek, J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102357 · Cited by 83
Metadata
- Authors
- Gigliobianco, M. R., Casadidio, C., Censi, R., & Di Martino, P.
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2018-08-21
- Volume
- 10
- Issue
- 3
- Pages
- 134
- ISSN
- 1999-4923 (ISSN-L)
- OpenAlex
- W2883347900
- Cited by
- 366
- References
- 126
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.